Vitrafy Life Sciences Limited (ASX: VFY)

Vitrafy Life Sciences Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	6.41	6.41	1.72	0.96
Short-Term Investments	0.04	0.04	0.04	0.02
Cash & Short-Term Investments	6.45	6.45	1.76	0.98
Cash Growth	-	266.55%	78.74%	-
Accounts Receivable	0.03	0.03	0.03	-
Other Receivables	2.17	2.17	2.11	1.94
Receivables	2.2	2.2	2.14	1.94
Prepaid Expenses	0.38	0.38	-	-
Other Current Assets	-	-	-	0.56
Total Current Assets	9.03	9.03	3.9	3.49
Property, Plant & Equipment	0.75	0.75	1.03	0.88
Total Assets	9.78	9.78	4.93	4.37
Accounts Payable	0.27	0.27	0.44	0.24
Accrued Expenses	0.36	0.36	0.32	0.23
Short-Term Debt	22.86	22.86	8.55	7.5
Current Portion of Leases	0.08	0.08	0.09	0.07
Other Current Liabilities	10.31	10.31	9.55	3.23
Total Current Liabilities	33.88	33.88	18.95	11.26
Long-Term Leases	0.39	0.39	0.54	0.34
Total Liabilities	34.38	34.38	19.56	11.64
Common Stock	5.19	5.19	4.92	4.83
Retained Earnings	-30.66	-30.66	-20.23	-12.42
Comprehensive Income & Other	0.87	0.87	0.68	0.32
Shareholders' Equity	-24.6	-24.6	-14.63	-7.27
Total Liabilities & Equity	9.78	9.78	4.93	4.37
Total Debt	23.33	23.33	9.19	7.91
Net Cash (Debt)	-16.88	-16.88	-7.43	-6.93
Net Cash Per Share	-5.50	-5.50	-2.52	-2.37
Filing Date Shares Outstanding	3.12	3.12	2.98	2.93
Total Common Shares Outstanding	3.12	3.12	2.98	2.93
Working Capital	-24.85	-24.85	-15.05	-7.77
Book Value Per Share	-7.90	-7.90	-4.91	-2.48
Tangible Book Value	-24.6	-24.6	-14.63	-7.27
Tangible Book Value Per Share	-7.90	-7.90	-4.91	-2.48
Machinery	0.74	0.74	0.73	0.64

Source: S&P Capital IQ. Standard template. Financial Sources.